BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bio-Kinetic Clinical Applications, Inc. Expands Phase I Capacity In Springfield, Missouri


10/19/2005 5:13:20 PM

SPRINGFIELD, Mo., Oct. 11 /PRNewswire/ -- Bio-Kinetic Clinical Applications, Inc. (Bio-Kinetic), a leading provider of Phase I clinical study services to the pharmaceutical and biotechnology industry, announced plans to build a new state-of-the-art 108 bed facility on its corporate campus, increasing its total capacity to 240 Phase I beds. The new facility is set to open during the second half of 2006.

Dale Bourg, Chairman and Chief Executive Officer, who founded Bio-Kinetic with Dave Koenigsfeld in 1994, said, "Increasing demand for our services has made it difficult to accommodate all of our valued clients. This additional capacity will allow us to meet current client needs and be prepared for increased demand as well."

Funding for this major expansion along with additional capital to purse other growth opportunities was part of a recently-announced investment by private equity funds managed by The Argentum Group and First Analysis Corporation. Dave Koenigsfeld, Chief Operating Officer, added, "In addition to the new beds, the new facility will also provide much needed office space for clients while they are on-site and will accommodate our growing employee base."

About Bio-Kinetic

Bio-Kinetic, http://www.bkca.us, is a drug development services company that designs and conducts Phase I clinical studies for branded pharmaceutical, bio-technology, and generic drug companies. The company owns and operates a 132-bed Phase I facility in Springfield, Missouri. It is currently expanding its capacity to 240 beds, which will position Bio-Kinetic as one of the larger independent Phase I facilities in the country. The Company is known for its clinical quality, having developed an outstanding reputation for study designs, recruiting and screening study participants, and collecting and reporting clinical data.

Bio-Kinetic Clinical Applications, Inc.

CONTACT: Rick Rhyner for Bio-Kinetic Clinical Applications,rrhyner@rhycom.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES